AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.

Clinically meaningful lung function activity, measured by ppFEV1 and LCI2.5,with follow-up through 1 year at dose selected for Phase 2 Durable ...

EMERYVILLE, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

EMERYVILLE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Memory swizzling is the quiet tax that every hierarchical-memory accelerator pays. It is fundamental to how GPUs, TPUs, NPUs, ...

Framed around advances in technology, design, product strategy and brand ambition, the event outlined a comprehensive upgrade of the marque.

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy ...

Kase reports a retail supply chain shift by 2026, driven by tariffs and tech gaps, prioritizing regionalization and ...

Look for IonQ to continue pursuing attractive opportunities in 2026. One deal is already on the horizon, assuming it doesn't ...

Managing your inbox is a never-ending task, which is why we should seek to simplify it as much as possible. When emails pile up, you start overthinking what you need to do—I know I do, anyway. But if ...

This study provides important evidence that negative affect is associated with slower cognitive processing in daily life, with findings replicated across three independent samples and supported by ...

Background Predicting progression to aortic valve replacement (AVR) in moderate aortic stenosis (AS) is challenging. This ...